Perinatal antecedents associated with hospitalization for bronchiolitis. A comparison with the Impact-RSV Sudy Group;Antecedentes perinatales y hospitalización por bronquiolitis. Comparación con el Impact-RSV Study Group

Anales Espanoles de Pediatria

Volumn 53, Issue 6, 2000, Pages 527-532

  Bonillo Perales, A ^a   Diez Delgado Rubio J ^a   Ortega Montes, A ^a   Infante Marquez P ^b   Jimenez Liria M R ^a   Batlles Garrido, J ^a   Lopez Munoz J ^a  

^a HOSPITAL TORRECÁRDENAS   (Spain)

^b Hospital Poniente Almería   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COMPARATIVE STUDY; HOSPITALIZATION; HUMAN; INCIDENCE; INFANT; NEWBORN; PREMATURITY; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICS; VIRAL BRONCHIOLITIS; VIRUS INFECTION;

BRONCHIOLITIS, VIRAL; HOSPITALIZATION; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0034568402     PISSN: 03024342     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ. Bronchiolitis-associated hospitalisations among US Children, 1980-1996. JAMA 1999; 382: 1440-1446.
2. Gellida Royo MJ, Maixé Ceballos J, Allué Martínez X, Closa Monasterolo R. Análisis epidemiológico de la bronquiolitis en la region sanitaria de Tarragona. An Esp Ped 1999; 50: 21-24.
3. Cabrera Roca G, Domínguez Ortega F, Lafarga Capuz B, Calvo Rosales J Estudio clínico-epidemiológico de la infección por virus respiratorio sincitial en el lactante An Esp Ped 1997; 46: 576-580.
4. Colinas Herrero J, Rodríguez del Corral C, Gómez Sorrigueta P, Fierro Urturi A, Muro Tudelilla JM, Jiménez Mena E. Bronquiolitis, Revisión de 152 casos y estudio comparativo del tratamiento con ribavirina An Esp Ped 1997; 46: 143-147.
5. Joffe S, Escobar GJ, Black SB, Armstrong MA, Lieu TA. Rehospitalization for respiratory syncytial virus among premature infants. Pediatrics 1999; 104: 894-899.
6. American Academy of Pediatrics, Committee on Infectious Diseases and Committee on Fetus and Newborn. Respiratory syncytial virus immune globulin intravenous Indications for use. Pediatrics 1997; 99: 645-650.
7. Storch GA Humanized monoclonal antibody for prevention of respiratory syncytial virus infection. Pediatrics 1998; 102: 648-650
8. The Impact-RSV Study Group. Palivizumab, a humanized respirators syncytial virus monoclonal antibody, reduces hospitalisation from respiratory syncytial virus infection in high-risk infants. Pediatrics 1998; 102: 531-537.
9. American Academy of Pediatrics. Committee on Infectious Diseases and Committee on Fetus and Newborn. Prevention of respiratory syncytial virus infections, indications for the use of palivizumab and update on the use of RSV-IVIG. Pediatrics 1998; 102: 1211-1216.
10. McConochie KM Bronchiolitis. What's in the name? Am J Dis Child 1983; 173: 11-13.
11. Groupe francophone de reanimation et d'urgencies pédiatriques Prise en charge des bronchiolitis aiguës du nourrisson. Propositions de la commission d'evaluation. Arch Pediatr 1996; 3 1191-1192.
12. Pérez-Yarza EG, De Frutos C, Mintegui J. Bronquiolitis En: Prandi F, ed. Programs de formación continuada en pediatría práctica. Barcelona: Prous Science, 2000; 37-68.
13. Behrendt CE, Decker MD, Burch DJ, Watson PH. International variation in the management of infants hospitalised with respiratory syncytial virus. International RSV Study Group. Eur J Pediatr 1998; 157: 215-220.
14. Alba Moreno F, Alsina Donadeu J Estudio clínico-epidemiológico de las enfermedades del tracto respiratorio inferior con sibilancias en menores de 2 años y factores de riesgo asociados. An Esp Ped 1999; 50: 379-383.
15. Sequeiros González A, Lirio Casero J. Bronquiolitis. Rev Esp Pediatr 1991; 47: 241-248.
16. Léon Léon MC, Dorao Martínez-Romillo P, García García S, Ruza Tarrío F. Prevención y terapéutica de la bronquiolitis: estado actual. An Esp Ped 1998; 49: 451-455.
17. Carbonell Estrany X, Quero Jiménez J y Comité de Estándares de la Sociedad Española de Neonatoiogía y Junta Directiva de la Sociedad Española de Neonatología. Recomendaciones para la prevención de la infección por virus respiratorio sincitial. An Esp Ped 2000; 52: 372-374.
18. Carbonell X, Giuffré L, Gorman WA, Kimpen JLL, Adam D, Valerius NH. Guidelines for use of Synagis (palivizumab), a humanized monoclonal antibody, for prevention of respiratory syncytial virus (RSV) disease in high risk infants: a consensus opinion. Infections in Medicine 1999; 16: 29-33
19. Thomas M, Bedford-Russel A, Sharland M. Hospitalisation for RSV infection in ex-preterm infants. Implications for use of RSV immune globulin Arch Dis CMd 2000; 83: 122-127.
20. Brooks AM, McBride JT, McConnochie KM, Aviram M, Long C, Hall CB. Predicting deterioration in previously healthy infants hospitalised with respiratory syncytial virus infection. Pediatrics 1999; 104: 463-467.
21. Graham XMT The epidemioloty of acute respiratory infections in children and adults: a global perspective Epidemiol Rev 1990; 12: 149-178.
22. McConnochie KM, Roghmann KJ, Liptak GS, Hospitalization for lower respiratory tract illness in infants: variation in rates among countries in New York State and areas wihin Monroe Country J Pediatr 1995; 126: 220-229.
23. Denny FW, Clyde WA. Acute lower respiratory tract infections in non hospitalised children. Pediatrics 1986; 108: 635-646
24. Meissner HC. Economic impact of viral respiratory disease in children. J Pediatr 1994; 124: S17-S21
25. Faverge B, Bonein M, Attou D, Benskhria S, Gratecos L Prévention de la bronchiolite à virus respiratoire syncytial dans un hôpital périphérique problèmes économiques et questions éthiques Arch Pediatr 2000 7, 429
26. Joffe S, Ray GT, Escobar GJ, Black SB, Lieu TA Cost-effectiveness of respiratory syncytial virus prophilaxis among preterm infants Pediatrics 1999; 104: 419-427.